GRIMAUD BRETT A. (SVP, GEN COUNSEL AND SECRETARY) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2025ACC: 0001415889-25-005349
Officer· SVP, GEN COUNSEL AND SECRETARY
Since Feb 2026
-14.53K
Net shares
Net seller
$140.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
14.53K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−14.53K
Price / share
$9.66
Trade value
$140.40K
% of position
4.4%
2/20/2025
333.35K→318.81K
Total
Net shares
−14.53K
Net value
-$140.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2025 | F · Tax Withholding | −14.53K | $9.66 | $140.40K | 4.4% | 333.35K | 318.81K |
| Total | −14.53K | -$140.40K | ||||||
Derivative Transactions0
No derivative transactions reported